Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis

ConclusionsPost hoc analyses showed that more cariprazine‐ than placebo‐treated patients with bipolar mania or schizophrenia had statistically significant and clinically meaningful CGI‐S improvement.

Source: International Journal of Clinical Practice - October 1, 2017 Category: Internal Medicine Authors: Suresh Durgam, Willie Earley, Kaifeng Lu, Gy örgy Németh, István Laszlovszky, Stephen Volk, Robert E. Litman Tags: ORIGINAL PAPER Source Type: research